PolyPid
PYPD
5 hedge funds and large institutions have $79.6K invested in PolyPid in 2023 Q4 according to their latest regulatory filings, with 1 funds opening new positions, 0 increasing their positions, 3 reducing their positions, and 0 closing their positions.
25% more funds holding
Funds holding: 4 → 5 (+1)
0.04% more ownership
Funds ownership: 1.24% → 1.28% (+0.04%)
15% less capital invested
Capital invested by funds: $93.2K → $79.6K (-$13.6K)
100% less repeat investments, than reductions
Existing positions increased: 0 | Existing positions reduced: 3
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
UBS Group
Zurich,
Switzerland
|
+$3.1K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Osaic Holdings
Scottsdale,
Arizona
|
-$504 |
| 2 |
SPIA
Steward Partners Investment Advisory
New York
|
-$28 |
| 3 |
YLHM
Yelin Lapidot Holdings Management
Tel Aviv,
Israel
|
-$4 |
PYPD Hedge Fund Activity: Q4 2023 in Review
5 of the 6,871 institutional investors tracked by Wall St. Rank reported a position in PolyPid (PYPD) for Q4 2023, worth a combined $79.6K — down 15% from $93.2K a quarter earlier.
Buyers outnumbered sellers: 1 fund opened new PYPD positions and 0 closed out — a net gain of 1 holder — while 0 added to existing stakes and 3 trimmed.
The largest buyer was UBS Group, opening a new position worth an estimated $3.1K. The largest seller was Osaic Holdings, cutting an estimated $504.
- 5 institutional investors held PolyPid (PYPD) as of Q4 2023, up from 4 in Q3 2023.
- Funds reported $79.6K of PolyPid stock for Q4 2023, down 15% quarter-over-quarter.
- 1 fund opened new PolyPid positions in Q4 2023 and 0 closed out, a net change of +1 holder.
- The largest PolyPid buyer in Q4 2023 was UBS Group, an estimated $3.1K added.
- The largest PolyPid seller in Q4 2023 was Osaic Holdings, an estimated $504 sold.
Based on aggregated 13F filings for Q4 2023.